UNI-BIO GROUP(00690): Changes in shareholder equity framework

date
18:08 02/04/2026
avatar
GMT Eight
Liankang Biotechnology Group (00690) announced that the board of directors has been informed by Mr. Leung Kwok Lung (executive director and chairman of the board) and several controlled entities that, due to the family arrangements of the Leung family, of which Mr. Leung and his family members are members, there has been a change in shareholding (equity change).
UNI-BIO GROUP (00690) announcement, the Board of Directors has been informed by Mr. Leung Kwok-Long (Executive Director and Chairman of the Board) and several controlled entities that, due to the family arrangement of the Leung Family, changes in shareholding (shareholding changes) have occurred. As of the date of this announcement and immediately before and after the shareholding changes, the Leung Family's direct and indirect holdings in the Company have been maintained at 1.79 billion shares of the Company's shares, representing approximately 29.98% of the issued shares. It is expected that the 209.4 million shares held by MJKPC will also be transferred to Skill Hand Limited in due course. The trust structure will terminate upon completion of this transfer. Therefore, despite the shareholding changes, all 1.79 billion shares will at all times be controlled by the same close family (i.e. the Leung Family). The shareholding changes are purely part of the Leung Family's family arrangement and will not increase or decrease the public shareholding, therefore, it is not expected to have any impact on the market. Mr. Leung will continue to serve as Chairman and Executive Director of the Board. It is not expected that the composition of the Board will change as a result of the shareholding changes.